Form 4 for CRM Salesforce
Accepted 2024-05-23 00:00:00 ET · period of report 2024-05-22 · accession 0001127602-24-016463 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-05-23 | 2024-05-22 | CRM | Millham Brian | Pres, COO | S - Sale+OE | $283.41 | -6,162 | 0 | -100% | -$1.75M |
| DM | 2024-05-23 | 2024-05-22 | CRM | Millham Brian | Pres, COO | M - OptEx | $206.73 | +6,162 | 4,055 | New | +$1.27M |
| DM | 2024-05-23 | 2024-05-22 | CRM | Millham Brian | Pres, COO | M - OptEx | $0.00 | -6,162 | 20.2K | -23% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-22 | S | D | 6,162 | $283.41 | 0 | D | — | — | |
| 2 | Common | Common Stock | 2024-05-22 | M | A | 2,107 | $218.21 | 6,162 | D | — | — | |
| 3 | Common | Common Stock | 2024-05-22 | M | A | 2,038 | $186.51 | 2,038 | D | — | — | |
| 4 | Common | Common Stock | 2024-05-22 | M | A | 2,017 | $215.17 | 4,055 | D | — | — | |
| 5 | Derivative | Non-qualified Stock Option (Right to Buy) | 2024-05-22 | M | D | 2,038 | $0.00 | 69,283 | D | $186.51 · 2024-03-22 to 2030-03-22 | 2,038 Common Stock | (F2) Option is exercisable and vests over four years at the rate of 25% on March 22, 2024, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months. |
| 6 | Derivative | Non-qualified Stock Option (Right to Buy) | 2024-05-22 | M | D | 2,107 | $0.00 | 46,347 | D | $218.21 · 2023-03-22 to 2029-03-22 | 2,107 Common Stock | (F4) Option is exercisable and vests over four years at the rate of 25% on March 22, 2023, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months. |
| 7 | Derivative | Non-qualified Stock Option (Right to Buy) | 2024-05-22 | M | D | 2,017 | $0.00 | 20,179 | D | $215.17 · 2022-03-22 to 2028-03-22 | 2,017 Common Stock | (F3) Option is exercisable and vests over four years at the rate of 25% on March 22, 2022, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months. |